Rxsight Inc (RXST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 13,994 | N/A | N/A |
| Marketable Securities | 54,981 | N/A | N/A |
| Receivables | 2,865 | N/A | N/A |
| Inventories | 8,288 | N/A | N/A |
| TOTAL | $81,500 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 13,287 | N/A | N/A |
| Other Non-Current Assets | 5,890 | 0 | 0 |
| TOTAL | $19,177 | $N/A | $N/A |
| Total Assets | $100,677 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,134 | 0 | 0 |
| Accrued Expenses | 4,174 | N/A | N/A |
| Other current liabilities | 5,018 | N/A | N/A |
| TOTAL | $11,600 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 24,399 | N/A | N/A |
| Other Non-Current Liabilities | 61,992 | 0 | 0 |
| TOTAL | $86,391 | $N/A | $N/A |
| Total Liabilities | $97,991 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 80,780 | N/A | N/A |
| Retained earnings | -430,588 | N/A | N/A |
| Other shareholders' equity | 352,494 | 0 | 0 |
| TOTAL | $2,686 | $N/A | $N/A |
| Total Liabilities And Equity | $100,677 | $0 | $0 |